| Name | RET-IN-15 |
|---|
| Description | RET-IN-15 is a rearranged during transfection (RET) kinase inhibitor extracted from patent WO2021115457A1 compound 51. RET-IN-15 can be used for the research of cancer[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C27H28N8O2 |
|---|---|
| Molecular Weight | 496.56 |